FDA OKs Trifarotene, First New Retinoid Acne Cream in 20 Years FDA OKs Trifarotene, First New Retinoid Acne Cream in 20 Years

Trifarotene cream 0.005% (Aklief), approved for patients aged 9 years or older, is the first topical treatment specifically studied and proven to treat acne vulgaris on both the face and trunk.FDA Approvals

Source: Medscape Dermatology Headlines - October 7, 2019 Category: Dermatology Tags: Dermatology News Source Type: news